Leaf4Life

KizaVie™ (LEAF-4L6715) is a late-stage, first-in-class therapeutic platform designed to restore oxygen diffusion at the microvascular level—addressing a fundamental physiological limitation that drives mortality, treatment resistance, and healthcare burden across critical care, oncology, trauma, and chronic disease. Unlike conventional therapies that increase oxygen supply, KizaVie™ enables oxygen delivery at the tissue level, directly targeting a core biological failure not addressed by current standards of care.